Search This Blog

Thursday, April 25, 2019

Bristol-Myers says Phase 2 CheckMate -714 trial did not meet primary endpoints

https://thefly.com/landingPageNews.php?id=2897264

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.